Table 2.
Change differences in the anthropometrical measurements, endothelial function, and biochemical characteristics in the crossover analysis.
| Parameters | AGE | Placebo | P value |
|---|---|---|---|
| Change differences (n = 43) |
Change differences (n = 43) |
||
| SBP (mm Hg) | −2.59 ± 1.91 | −1.72 ± 1.60 | 0.727* |
| DBP (mm Hg) | −1.07 ± 1.32 | −0.31 ± 1.17 | 0.670* |
| BMI (kg/m2) | 0.01 ± 0.21 | −0.11 ± 0.17 | 0.952# |
| WC (cm) | −0.99 ± 0.47 | 0.32 ± 0.50 | 0.062* |
| HC (cm) | −0.91 ± 0.39 | −0.39 ± 0.58 | 0.462# |
| WHR | −0.001 ± 0.004 | −0.005 ± 0.005 | 0.358* |
| Glucose (mg/dL) | 2.04 ± 1.68 | 3.46 ± 1.87 | 0.766# |
| Cholesterol (mg/dL) | −4.41 ± 4.47 | 6.0 ± 4.27 | 0.172# |
| LDL-C (mg/dL) | 3.94 ± 5.32 | 6.51 ± 4.46 | 0.869# |
| HDL-C (mg/dL) | −1.64 ± 0.86 | −1.16 ± 0.69 | 0.911# |
| TG (mg/dL) | −18.76 ± 12.42 | −3.98 ± 13.84 | 0.453# |
| CRP (mg/L) | 0.21 ± 0.85 | 0.07 ± 0.77 | 0.976# |
| IL-6 (units/mL) | 0.08 ± 0.16 | 0.01 ± 0.18 | 0.682 # |
| Adiponectin (ng/mL) | 313.79 ± 179.44 | −271.88 ± 187.18 | 0.027∗Ψ |
| Leptin (ng/mL) | −1.67 ± 1.68 | −0.79 ± 1.26 | 0.993# |
| Insulin (μU/mL) | −2.94 ± 2.60 | 2.26 ± 1.38 | 0.269# |
| HOMA index | −0.67 ± 0.70 | 0.67 ± 0.34 | 0.142# |
| FMV (%) | −0.81 ± 5.09 | −1.34 ± 9.78 | 0.836* |
SBP: systolic blood pressure; DBP: diastolic blood pressure; BMI: body mass index; WC: waist circumference; HC: hip circumference; WHR: waist-hip ratio; LDL-C: low density lipoprotein cholesterol; HDL-C: high density lipoprotein cholesterol; TG: triglycerides; CRP: C-reactive protein; IL-6: interleukin 6; FMV: flow-mediated vasodilatation. Values are expressed as mean ± SEM. *AGE group versus placebo group with Student's t-test. #AGE group versus placebo group with Wilcoxon signed-ranks test. Ψ P < 0.05.